[A retrospective analysis of population type variability of the region V3 gp120 in HIV infected patients with a unified infection focus]

Vopr Virusol. 2003 Jul-Aug;48(4):20-6.
[Article in Russian]

Abstract

Regions of HIV-1 genome, encoding the V3 gp120 region, were sequenced in materials that were sampled from persons belonging to the category of individuals infected from a single source during the Rostov-Elista outbreak. The samples were obtained in 1991-1992 (10 pieces) and in 2000-2001 (16 pieces), which amounts to 8% and 13%, respectively, of a total number of patients infected by the beginning of 1990. It was established that the level of the population variability of amino-acid sequences in region V3 amounted, in 1991-1992, to 5.2% and increased to 9.1% in the samples of 2000-2001. A comparison of amino-acid sequences in region V3 from the collections of 1991-1992 and of 2000-2001 revealed the below amino-acid substitutions: from Ser13 to His, from Ley14 to Phe, from Phe to Ley and from Ley to Ala. An analysis of V3 B-epitope showed that the basic trend of its evolution consists in reciprocal transitions of L to F in position 14 and of F to L in position 20. Such substitutions ensure further changes at the "top" of the V3-loop from GPG to APG.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Amino Acid Sequence
  • Amino Acids / analysis
  • B-Lymphocytes / immunology
  • B-Lymphocytes / virology
  • Cohort Studies
  • Disease Outbreaks*
  • Epitopes / analysis
  • Genetic Variation*
  • Genome, Viral
  • HIV Envelope Protein gp120 / genetics*
  • HIV Envelope Protein gp120 / immunology
  • HIV Infections / blood
  • HIV Infections / epidemiology*
  • HIV Infections / virology
  • HIV-1*
  • Humans
  • Molecular Sequence Data
  • Peptide Fragments / genetics*
  • Peptide Fragments / immunology
  • Retrospective Studies
  • Russia / epidemiology
  • Sequence Alignment

Substances

  • Amino Acids
  • Epitopes
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments